Nanoparticle-based pazopanib shows promise in OA

Nat Rev Rheumatol. 2024 May;20(5):253. doi: 10.1038/s41584-024-01104-w.
No abstract available

Publication types

  • News

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / therapeutic use
  • Humans
  • Indazoles* / therapeutic use
  • Nanoparticles
  • Osteoarthritis* / drug therapy
  • Pyrimidines* / administration & dosage
  • Pyrimidines* / therapeutic use
  • Sulfonamides* / administration & dosage
  • Sulfonamides* / therapeutic use

Substances

  • pazopanib
  • Pyrimidines
  • Indazoles
  • Sulfonamides
  • Angiogenesis Inhibitors